Laser acupuncture may boost white blood cells during chemo
NCT ID NCT07075809
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether laserpuncture (a needle-free form of acupuncture using lasers) could reduce low white blood cell counts caused by chemotherapy and improve quality of life in 30 adults with head and neck cancer. Participants received either real or sham laserpuncture during their first chemotherapy cycle. Researchers measured white blood cell counts and used questionnaires to assess quality of life before and after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female patients with head and neck cancer, aged 18-60 years. * Head and neck cancer patients diagnosed through histopathological examination, with cancer stages II to IV. * Head and neck cancer patients undergoing chemotherapy with platinum-based chemotherapy drugs combined with 5-Fluorouracil, in the first treatment cycle. * Leukocyte count greater than 5000/mm³. * Patients who have signed informed consent and are willing to participate in the study until completion. * Normal Mini-Mental State Examination (MMSE) score (27-31). Exclusion Criteria: * Patients with cancer lesions, ulcers, acute dermatitis, or exacerbation of chronic skin diseases at the selected acupuncture points. * Patients with deformities or anatomical abnormalities of the ear. * Patients with fever (body temperature \>38ºC). * Patients with hemodynamic instability (patient vital signs outside the normal limits. Normal vital signs include axillary temperature of 36.5 - 37.5ºC, systolic blood pressure 102 - 131 mmHg, diastolic blood pressure 61 - 83 mmHg, pulse rate 60 - 100 beats/minute. Unstable if respiratory rate is above 25 breaths/minute or SpO2 \< 90%). Patients with a history of allergy to laser irradiation (skin hypersensitivity due to exposure to specific light). \- Patients with a history of uncontrolled seizures or epilepsy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill HG146 put to the test against rare head and neck cancer
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Five days of radiation instead of weeks: a new test for head and neck cancer